FHLC News and Press, Fidelity MSCI Health Care Index From 06/10/21

Consumer Services climb to the top performing sector in May. Supply constraints limit output for basic material and consumer good sectors. Broadly positive economic conditions point to further closing in on the removal of accommodative policy. For further details see: U....

Historic efforts to develop COVID-19 vaccines have had two huge effects on the industry. Efforts to waive patents on COVID-19 vaccines to help reduce costs for emerging markets are also stuck. Since healthcare is an industry that has a profound impact on society, there’s a ...

FHLC looks attractively priced relative to major equity ETF alternatives such as SPY. Being "over-weight" the healthcare sector appears to be attractive also from a cyclical investing perspective. Further, FHLC routinely makes lows versus SPY before "reverting to the mean", and we...

The US recovery is gaining momentum as the country reopens parts of its economy — boosted by government stimulus and vaccine rollouts. The impact of the global pandemic opened up new opportunities for equity investors. While growth stocks outperformed over much of the last ...

Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare

In January 2020, only 0.24% of total medical claims in the U.S. were telemedicine-related. One year later, they totaled 7%. It took 15 years for e-commerce penetration to rise from less than 1% to over 7%. The pandemic helped telemedicine do it in one. Population-wide immunity to ...

Current economic data is certainly strong - although not universally so - but the bond and currency markets may be pointing to some weakness ahead. The copper to gold ratio which peaked in early March, leading bond yields by a full month, has recently resumed its uptrend. The comm...

If you were investing heavily in tech/growth stocks over the past 11 years, we wish to congratulate you. We're not here to say that the next 11 years won't be the same, rather to suggest that you should treat your portfolio the same way you treat your body. If you've vaccinated yo...

Since U.S. Treasury bonds have fallen more than -20% in value, it looks like we might've seen a short-term bottom and an opportunity to profit in the bond market. Which sectors are performing well in the intermediate term, as well as those that are taking a breather in the short term....

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of thi...